U.S. Patent Disclosures
Ariad Pharmaceuticals Inc., of Cambridge, Mass., received U.S. Patent No. 8,114,874, titled "Substituted Acetylenic Imidazo[1,2-B] Pyridazine Compounds as Kinase Inhibitors." It provides composition-of-matter protection for investigational pan-Bcr-Abl inhibitor ponatinib.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.